Search Results

Bimatoprost implant reduces IOP for 2 years or more.

• Authors : Charters, Lynda

Subjects: *BIMATOPROST; *DRUG approval; *GLAUCOMAUNITED States. Food & Drug Administration

• Source: Ophthalmology Times. Jan2022, Vol. 47 Issue 1, p14-15. 2p.

Record details

CONTINUING MEDICAL EDUCATION. 3 Things You Should Know About Glaucoma.

• Authors : Smith, Oluwatosin U.¹

Subjects: *BIMATOPROST; *GLAUCOMA; *INTRAOCULAR pressure

• Source: Ophthalmology Times. May2021, Vol. 46 Issue 8, p32-33. 2p.

Record details

Bimatoprost implant: Taking a holiday from glaucoma drops.

• Authors : Charters, Lynda; Bunin, Lisa

Subjects: BIMATOPROST; GLAUCOMA; CONTROLLED release drugs

• Source: Ophthalmology Times. Aug2022, Vol. 47 Issue 8, p24-24. 1p.

Record details

Bimatoprost SR may offer long-term lowering of IOP: Study zeroes in on the sustained mechanism of action of the therapeutic.

• Authors : Charters, Lynda; Rhee, Douglas J.

Subjects: BIMATOPROST; INTRAOCULAR pressure; MATRIX metalloproteinasesOHIO

• Source: Ophthalmology Times. May2022, Vol. 47 Issue 5, p20-20. 1p.

Record details

Exploring early glaucoma promise with noninvasive bimatoprost insert: Polymer ring effectively elutes daily dosages for up to 6 months.

• Authors : Gebhart, Fred

Subjects: *GLAUCOMA; *BIMATOPROST

• Source: Ophthalmology Times Europe. May2017, Vol. 13 Issue 4, p32-33. 2p.

Record details

Sustained-release bimatoprost implant addresses challenges of adherence.

Subjects: *BIMATOPROST; *GLAUCOMA treatment; *PROSTAGLANDINS

• Source: Ophthalmology Times Europe. Jan/Feb2016, Vol. 12 Issue 1, p16-17. 2p.

Record details

Nitric-oxide-donating drugs: significant IOP lowering with once-daily dosing Advantages of nitric-oxide-donating drugs compared with timolol.

• Authors : Charters, Lynda; Schwartz, Gail F.¹

Subjects: *BIMATOPROST; *CYCLIC guanylic acid; *ANGLE-closure glaucoma

• Source: Ophthalmology Times Europe. Apr2019, Vol. 15 Issue 3, p28-29. 2p.

Record details

Therapeutic option improves outflow through trabecular meshwork: Broad utility of netarsudil for ROCK inhibition across spectrum of glaucoma.

• Authors : Sawhney, Gagan

Subjects: *BIMATOPROST; *AMIODARONE; *GLAUCOMA

• Source: Ophthalmology Times Europe. Mar2019, Vol. 15 Issue 2, p30-31. 2p.

Record details

Bimatoprost implant reduces intraocular pressure for 2 years or more: Physicians find that additional treatment is not required for many patients.

• Authors : Charters, Lynda; Medeiros, Felipe¹

Subjects: *INTRAOCULAR pressure; *BIMATOPROST; *PHYSICIANS

• Source: Ophthalmology Times Europe. Mar2022, Vol. 18 Issue 2, p12-12. 1p.

Record details

Ocular insert sustains drug delivery.

Subjects: *BIMATOPROST; *INTRAOCULAR pressure; *DRUG delivery systems

• Source: Ophthalmology Times Europe. Jan/Feb2016, Vol. 12 Issue 1, p10-11. 2p.

Record details